Heartcore Enterprises, INC

Market Movers (8-K)

NASDAQ
HeartCore Enterprises has completed the strategic divestiture of its 51% stake in Sigmaways to streamline operations and reduce financial drag.
NASDAQ
HeartCore Enterprises announced its first quarter 2026 financial results, reporting revenues of $1.2 million and a net loss of $2.0 million, with a focus on expanding its Go IPO client base.
Worse than expected
NASDAQ
HeartCore Enterprises announced it has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market.
NASDAQ
HeartCore Enterprises has implemented a 1-for-20 reverse stock split effective April 2, 2026, to consolidate its outstanding common shares.
NASDAQ
HeartCore Enterprises, Inc. announced a 1-for-20 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.
Worse than expected
NASDAQ
HeartCore Enterprises, Inc. amended its bylaws to clarify that stockholders are not liable for the company's attorney fees in internal corporate claims.

Quarterly Earnings (10-Q)

NASDAQ
HeartCore Enterprises reported a significant revenue decrease in Q1 2026, primarily due to challenges in its customized software development and services segment, alongside a substantial drop in gross profit margin.
Worse than expected
Capital raise
NASDAQ
HeartCore Enterprises reported a significant net loss in Q3 2025, driven by a sharp revenue decline in its consulting services and the strategic divestiture of its Japan software business.
Worse than expected
Capital raise
Delay expected
NASDAQ
HeartCore Enterprises reported a significant turnaround to net income in Q2 2025, driven by strong software sales and cost reductions, despite a decline in overall six-month revenue and ongoing Nasdaq compliance challenges.
Capital raise
Worse than expected
NASDAQ
HeartCore Enterprises' Q1 2025 results reveal a decrease in revenue and a widened net loss, influenced by reduced software sales and IPO consulting revenue, despite efforts to streamline operations.
Worse than expected
Capital raise
NASDAQ
HeartCore Enterprises saw a significant increase in revenue and a return to profitability in Q3 2024, primarily driven by the success of its GO IPO consulting services.
Better than expected
NASDAQ
HeartCore Enterprises experienced a significant decrease in revenue and a widening net loss in the second quarter of 2024, compared to the same period last year.
Worse than expected

Annual Reports (10-K)

NASDAQ
HeartCore Enterprises reported a strategic shift in 2025, divesting its Japanese software business to focus on U.S. IPO consulting services for Japanese companies, alongside a significant net income increase driven by discontinued operations.
Delay expected
Worse than expected
Capital raise
NASDAQ
HeartCore Enterprises' annual report reveals a year of strategic shifts, including growth in consulting services offsetting declines in core divisions, alongside significant non-cash transactions and a focus on global expansion.
Worse than expected
NASDAQ
HeartCore Enterprises files its 2023 annual report, including amendments to executive employment agreements and details on financial performance and business operations.
Worse than expected
Capital raise

Insider Trading (Form 4)

NASDAQ
HeartCore Enterprises, Inc. Director Daishin Yasui sold 110,000 shares of common stock in late May 2025, reducing his beneficial ownership to 2,201,756 shares and ceasing to be a 10% stockholder.
Worse than expected
NASDAQ
Daishin Yasui, a Director and 10% owner of HeartCore Enterprises, Inc. (HTCR), reported selling 10,869 shares of common stock in late May 2025.
Worse than expected
NASDAQ
Daishin Yasui, a director at HeartCore Enterprises, reported selling 2,500 shares of common stock at a price of $1.055 per share on March 21, 2025.
NASDAQ
Director Yasui Daishin of HeartCore Enterprises, Inc. reports selling 300 shares of common stock at $0.95 per share on March 19, 2025.
NASDAQ
A HeartCore Enterprises executive, Keisuke Kuno, sold 26,000 shares of common stock in multiple transactions on November 19, 2024.
NASDAQ
HeartCore Enterprises CEO Sumitaka Yamamoto reported a sale of 7,110 shares and a grant of 45,938 shares, while also correcting a previously reported beneficial ownership amount.

Proxy Statements (Def-14A)

NASDAQ
HeartCore Enterprises, Inc. announces its 2025 Virtual Annual Meeting to elect directors and ratify auditors, alongside significant corporate governance changes.
NASDAQ
HeartCore Enterprises, Inc. announced a $2 million preferred stock sale and a $25 million equity purchase agreement, alongside a planned reverse stock split to maintain Nasdaq listing.
Delay expected
Capital raise
NASDAQ
HeartCore Enterprises is holding a virtual annual meeting on September 27, 2024, to vote on the election of directors, a reverse stock split, and the ratification of its accounting firm.
Worse than expected

New Public Companies (S-1)

NASDAQ
HeartCore Enterprises, Inc. filed an S-1/A to register the resale of up to 24 million shares by a selling stockholder and detail a $25 million equity purchase agreement, while also addressing Nasdaq listing compliance issues.
Capital raise
NASDAQ
HeartCore Enterprises, a Tokyo-based software company, has entered into agreements for up to $25 million in equity financing and convertible preferred stock to bolster its growth initiatives and address critical Nasdaq listing deficiencies, though these actions will result in substantial shareholder dilution.
Capital raise
Worse than expected

Schedule 13G - Passive Investments

NASDAQ
Hnatko Capital Inc. and Christopher Hnatko report beneficial ownership of 7.1% of HeartCore Enterprises, Inc. common stock.
NASDAQ
Crom Structured Opportunities Fund I, LP has filed an amended Schedule 13G, disclosing a 4.9% beneficial ownership stake in Heartcore Enterprises, Inc., including common stock and convertible preferred shares subject to a 4.99% ownership blocker.
NASDAQ
Crom Structured Opportunities Fund I, LP has filed a Schedule 13G, disclosing a passive beneficial ownership of 5.6% in Heartcore Enterprises, Inc.'s common stock.